Permeability of tuberculous cavities to antituberculosis drugs.
D000328:Adult; D000995:Antitubercular Agents / Q000378:metabolism*; D002207:Capreomycin / Q000008:administration & dosage / Q000378:metabolism; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000378:metabolism; D005000:Ethionamide / Q000378:metabolism; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage / Q000378:metabolism; D008168:Lung / Q000378:metabolism*; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D010539:Permeability; D012293:Rifampin / Q000378:metabolism; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000378:metabolism* / Q000382:microbiology
D000995:Antitubercular Agents; D002207:Capreomycin; D007612:Kanamycin; D004977:Ethambutol; D005000:Ethionamide; D012293:Rifampin